AARP, P4AD blast bill extending drugmakers’ exemption from Medicare negotiation 

The Big Story

AARP, P4AD blast bill extending drugmakers’ exemption from Medicare negotiation

The AARP and Patients for Affordable Drugs Now (P4AD) are speaking out against a bill that would extend the time that a drug would have to be on the market before it could be eligible for Medicare negotiations, saying it would force consumers to continue “bearing the burden of high prices.”

© Photo credit

In a letter provided first to The Hill and addressed to congressional leadership, AARP and P4AD stated plainly that the Ensuring Pathways to Innovative Cures (EPIC) Act “does not serve the American taxpayers and would instead block or delay patients’ access to lower prescription drug prices.”

The bill, introduced by North Carolina Reps. Greg Murphy (R) and Don Davis (D), would add four years